recent articles

At the Interim Analysis, 7.3 Percent of Patients Who Received Molnupiravir Were Hospitalized Through Day 29, Compared With 14.1 Percent of Placebo-Treated Patients Who were Hospitalized or Died Merck Plans to Seek Emergency Use Authorization...

Findings of multi-site study highlight potential of technology in real-world practice PHILADELPHIA – October 5, 2021 – Proscia®, a leading provider of digital and computational pathology solutions, has released study results on new...

AIRA Matrix CEO, Chaith Kondragunta will be speaking at Intelligent Health 2021 on the application of Deep Learning applications that speed up the preclinical phase of drug discovery and development. The Tech Talk titled “Using Deep...

A preview of arguments to come After a tedious day of bickering, Victoria Sung appeared like manna from heaven — to tell us that Theranos’ tests sucked. Sung worked at Celgene when it contracted with Theranos. Her testimony was brief and...

Breaking Away from the Traditional Siloes Hundreds of meetings with senior healthcare executives in 2021 have shown us a growing desire for digitizing and automating critical oncology workflows -- from diagnosis to case reporting, to cancer...

September 30, 2021

Replace Me?

As a college student I was told pathologists would be replaced by flow cytometry As a medical student I was told pathologists would be replaced by gene chips As a pathology resident I was told pathologists would be replaced by PCR and...

OR

platinum partners

gold partners

Silver Partners

Media Partners